Skip to NavigationSkip to content

COPD: Novel Therapeutics and Management Strategies

Monday, October 22, 2012 - Tuesday, October 23, 2012
Copthorne Tara Hotel
London, United Kingdom

Event Type: Conference

SMi is proud to present their 4th annual conference on COPD, with presentations from the biggest players in the field. This year’s event promises to be a perfect forum for discussions and debates with key opinion leaders from industry and academia.


Key Benefits of Attending:


  • Consider developments in the modelling and management of exacerbations of COPD
  • Evaluate unique complexities of COPD pathophysiology
  • Develop combination and oxygen therapies within COPD - learn about triple therapies and novel therapies within the treatment of COPD
  • Hear from leading industry professionals on the current clinical trials process and rapid proof of concept studies
  • Analyse all phases of the discovery process, from pre-clinical modelling, phase 2 studies all the way through to modelling clinical outcomes
  • Network with and learn from key industry professional and research leading academics
  • Discuss the latest in health economics for COPD drugs


Hear from our expert speaker line-up including:

Sebastian Johnston,
Professor of Respiratory Medicine, Imperial College School of Medicine (N.H.L.I.)

Wisia Wedzicha, Professor of Respiratory Medicine, University College London

Ewan Walters, Medical Director, Teva UK

Liz Hardaker, Investigator II, Novartis

Nestor Molfino, Vice President, Clinical Development, Medimmune

Dirk Bredbroeker, Head of Clinical Science Respiratory/Immunology, Takeda

Matthew Catley, Team Leader, AstraZeneca

Frank Thielmann, Operational Lead, Inhalation New Solids, Novartis

Louise Donnelly, Reader in Respiratory Cell Biology, Imperial College London

Edwin Chilvers, Professor of Respiratory Medicine, University of Cambridge

PLUS! Two interactive half day post-conference workshops
Wednesday 24th October 2012, Copthorne Tara Hotel, London UK

Developing Inhalation Devices
In Association with Inamed GmbH
8.30am -12.30 pm

COPD Translational Biomarker Development
In Association with AstraZeneca & Truly Translational AB
1.30pm – 5.30pm

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches